Related references
Note: Only part of the references are listed.Continuous-flow left ventricular assist device exchange: Clinical outcomes
Takeyoshi Ota et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2014)
Fulminant Myocarditis
Fredric Ginsberg et al.
CRITICAL CARE CLINICS (2013)
Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program)
Sylvain Beurtheret et al.
EUROPEAN HEART JOURNAL (2013)
Pathogenesis and diagnosis of myocarditis
Chantal Elamm et al.
HEART (2012)
Bridging cardiogenic shock patients with short-term ventricular support at a community hospital to long-term ventricular support at a tertiary hospital
Jose Gonzalez-Costello et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2012)
Safe Transport of Critically Ill Adult Patients on Extracorporeal Membrane Oxygenation Support to a Regional Extracorporeal Membrane Oxygenation Center
Jeffrey Javidfar et al.
ASAIO JOURNAL (2011)
Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support
Mariana Mirabel et al.
CRITICAL CARE MEDICINE (2011)
Telmisartan ameliorates experimental autoimmune myocarditis associated with inhibition of inflammation and oxidative stress
Vijayakumar Sukumaran et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Myocarditis
Lori A. Blauwet et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2010)
Sudden Deaths in Young Competitive Athletes Analysis of 1866 Deaths in the United States, 1980-2006
Barry J. Maron et al.
CIRCULATION (2009)
Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study
Andrea Frustaci et al.
EUROPEAN HEART JOURNAL (2009)
Anti-inflammatory effects of eplerenone on viral myocarditis
Jie Xiao et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Medical Progress: Myocarditis.
Leslie T. Cooper
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Usefulness of Immunosuppression for Giant Cell Myocarditis
Leslie T. Cooper et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Predictors of outcome in patients with suspected myocarditis
Ingrid Kindermann et al.
CIRCULATION (2008)
Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis
Thomas J. Bahk et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Effect of the angiotensin II receptor blocker olmesartan on the development of murine acute myocarditis caused by coxsackievirus B3
Y Seko
CLINICAL SCIENCE (2006)
Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death
A Fabre et al.
HEART (2006)
Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property
ZY Yuan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Captopril prevents experimental autoimmune myocarditis
LM Godsel et al.
JOURNAL OF IMMUNOLOGY (2003)
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis
LM Godsel et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function
A Mekontso-Dessap et al.
ANNALS OF THORACIC SURGERY (2001)
Mechanical circulatory support for patients with acute-fulminant myocarditis
MA Acker
ANNALS OF THORACIC SURGERY (2001)
Definition of inflammatory cardiomyopathy (myocarditis): On the way to consensus - A status report
B Maisch et al.
HERZ (2000)
Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.
RE McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The European study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID) -: First epidemiological results
G Hufnagel et al.
HERZ (2000)
Share Paper
